Daily Supplementation of D-ribose Shows No Therapeutic Benefits in the MHC-I Transgenic Mouse Model of Inflammatory Myositis

BACKGROUND: Current treatments for idiopathic inflammatory myopathies (collectively called myositis) focus on the suppression of an autoimmune inflammatory response within the skeletal muscle. However, it has been observed that there is a poor correlation between the successful suppression of muscle...

Descripción completa

Detalles Bibliográficos
Autores principales: Coley, William, Rayavarapu, Sree, van der Meulen, Jack H., Duba, Ayyappa S., Nagaraju, Kanneboyina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681851/
https://www.ncbi.nlm.nih.gov/pubmed/23785461
http://dx.doi.org/10.1371/journal.pone.0065970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681851/
https://www.ncbi.nlm.nih.gov/pubmed/23785461
http://dx.doi.org/10.1371/journal.pone.0065970

Ejemplares similares